CrystalGenomics Incorporation develops pharmaceutical and agricultural products by structure-based drug discovery technology.  The Company also provides structural proteomic analysis services for helping drug discovery process.

Contract for Sales or Supply

Lawsuit (Charging More Than Certain Amount)

Price Gauge
52-week Range	0.00 - 0.00
Market Cap (USDm)	0.00
P/E	0.00
Dividend (Yield)	0.00

Crystalgenomics Inc (083790 KS)

Contract for Sales or Supply

Lawsuit (Charging More Than Certain Amount)

Organization of Investor Relations Event

[Revised] Decision on Disposal of Shares or Investment Securities of Other Corporation

Decision on Disposal of Shares or Investment Securities of Other Corporation

Price Gauge

52-week Range

Market Cap (USDm)

P/E

Dividend (Yield)